DLD Asset Management’s Korro Bio KRRO Stock Holding History

DLD Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$95K	–	154
2021 Q1	$95K	Buy	+200	New	+$389K	﹤0.01%	117

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SDIC

South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

DLD Asset Management's KRRO Position: Q2 2021 in Review

DLD Asset Management sold out of Korro Bio (KRRO) in Q2 2021, closing a stake of 200 shares — an estimated $95K sold.

DLD Asset Management first reported a position in KRRO in Q1 2021 and held it in 1 quarter. The position peaked at $95K in Q1 2021. 91 funds tracked by Wall St. Rank hold KRRO as of Q2 2021.

DLD Asset Management reported no remaining Korro Bio position as of Q2 2021 after selling out during the quarter.
DLD Asset Management sold 200 Korro Bio shares in Q2 2021, an estimated $95K.
DLD Asset Management first reported a position in Korro Bio in Q1 2021 and held it in 1 quarter.
DLD Asset Management's Korro Bio position peaked at $95K in Q1 2021.
91 funds tracked by Wall St. Rank held Korro Bio as of Q2 2021.

Based on DLD Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.